BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34048062)

  • 1. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
    Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
    Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE genotype in patients with hemochromatosis and other liver diseases.
    Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
    Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Sandnes M; Vorland M; Ulvik RJ; Reikvam H
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440336
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis, Diagnosis and Treatment of Hemochromatosis.
    Zoller H; Henninger B
    Dig Dis; 2016; 34(4):364-73. PubMed ID: 27170390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
    Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
    Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload.
    Badar S; Busti F; Ferrarini A; Xumerle L; Bozzini P; Capelli P; Pozzi-Mucelli R; Campostrini N; De Matteis G; Marin Vargas S; Giorgetti A; Delledonne M; Olivieri O; Girelli D
    Am J Hematol; 2016 Jun; 91(4):420-5. PubMed ID: 26799139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene.
    Gouya L; Muzeau F; Robreau AM; Letteron P; Couchi E; Lyoumi S; Deybach JC; Puy H; Fleming R; Demant P; Beaumont C; Grandchamp B
    Gastroenterology; 2007 Feb; 132(2):679-86. PubMed ID: 17258727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
    Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC;
    J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network.
    Gallego CJ; Burt A; Sundaresan AS; Ye Z; Shaw C; Crosslin DR; Crane PK; Fullerton SM; Hansen K; Carrell D; Kuivaniemi H; Derr K; de Andrade M; McCarty CA; Kitchner TE; Ragon BK; Stallings SC; Papa G; Bochenek J; Smith ME; Aufox SA; Pacheco JA; Patel V; Friesema EM; Erwin AL; Gottesman O; Gerhard GS; Ritchie M; Motulsky AG; Kullo IJ; Larson EB; Tromp G; Brilliant MH; Bottinger E; Denny JC; Roden DM; Williams MS; Jarvik GP
    Am J Hum Genet; 2015 Oct; 97(4):512-20. PubMed ID: 26365338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of a hemochromatosis next-generation sequencing gene panel.
    Lanktree MB; Sadikovic B; Waye JS; Levstik A; Lanktree BB; Yudin J; Crowther MA; Pare G; Adams PC
    Eur J Haematol; 2017 Mar; 98(3):228-234. PubMed ID: 27753142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
    Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH
    Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642
    [TBL] [Abstract][Full Text] [Related]  

  • 16.  GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
    Levstik A; Stuart A; Adams PC
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare HFE variants are the most frequent cause of hemochromatosis in non-c282y homozygous patients with hemochromatosis.
    Hamdi-Rozé H; Beaumont-Epinette MP; Ben Ali Z; Le Lan C; Loustaud-Ratti V; Causse X; Loreal O; Deugnier Y; Brissot P; Jouanolle AM; Bardou-Jacquet E
    Am J Hematol; 2016 Dec; 91(12):1202-1205. PubMed ID: 27518069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers.
    Deugnier Y; Morcet J; Lainé F; Hamdi-Roze H; Bollard AS; Guyader D; Moirand R; Bardou-Jacquet E
    J Hepatol; 2019 Jan; 70(1):118-125. PubMed ID: 30244162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.